Ignite Creation Date:
2025-12-25 @ 3:36 AM
Ignite Modification Date:
2025-12-26 @ 2:20 AM
Study NCT ID:
NCT00861705
Status:
COMPLETED
Last Update Posted:
2025-09-30
First Post:
2009-03-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07-21
Start Date Type:
ACTUAL
Primary Completion Date:
2014-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-09-02
Completion Date Type:
ACTUAL
First Submit Date:
2009-03-12
First Submit QC Date:
None
Study First Post Date:
2009-03-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-01-12
Results First Submit QC Date:
None
Results First Post Date:
2015-03-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-10
Last Update Post Date:
2025-09-30
Last Update Post Date Type:
ESTIMATED